---
title: "NATCO Pharma's Consolidated Profit Declines in Fiscal Q3; Shares Plunge 19%"
date: "2025-02-13 14:49:25"
summary: "NATCO Pharma witnessed a decline in its consolidated attributable profit to 1.33 billion Indian rupees in the fiscal third quarter ended Dec. 31, 2024, against 2.13 billion rupees a year ago. Earnings per share contracted to 7.43 rupees compared with the year-ago figure of 11.88 rupees, according to a Wednesday..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

NATCO Pharma witnessed a decline in its consolidated attributable profit to 1.33 billion Indian rupees in the fiscal third quarter ended Dec. 31,Â 2024, against 2.13 billion rupees a year ago.

Earnings per share contracted to 7.43 rupees compared with the year-ago figure of 11.88 rupees, according to a Wednesday filing to the Indian stock exchanges by the pharmaceutical manufacturer.

Revenue from operations in fiscal Q3 also fell to 4.75 billion rupees from 7.59 billion rupees a year earlier.

The company's board declared a third interim dividend of 1.50 rupees per equity share of 2 rupees apiece for the fiscal year ending March 31. The dividend will be paid from Feb. 28 to shareholders on record Feb. 18.

Shares of the company sank over 19% in recent trade.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250213:G2467260:0/)
